Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pathologic Complete Response × Epirubicin × Clear all

Phase

Status

Withdrawn 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Carcinoma, Hepatocellular 1

Interventions

pertuzumab 1 cc-486 1 Trastuzumab 1 Sulindac 1 Magnetic Resonance Spectroscopy 1 Epirubicin 1 Docetaxel 1 Cytarabine 1 Carboplatin 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Henan Cancer Hospital

Phase 3 Withdrawn

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡